Latest News
Quixant surges on integration of Denistron
Gaming technology company Quixant announced its interim financial results for the six months to 30 June on Wednesday, which included a full six month contribution by Densitron Technologies, acquired in November 2015.
UK gov to trigger Article 50 in January, says Farage
The British government is likely to trigger formal Brexit talks with the European Union in January 2017, the former leader of Ukip, Nigel Farage said on Wednesday.
Britain and Argentina seek closer bilateral trade ties
The UK is seeking closer trade links with Argentina and greater co-operation regarding shipping and the oil industry affecting the Falklands Islands.
Headlam appoints Steve Wilson as CEO
Floorcoverings distributor Headlam appointed Steve Wilson chief executive on Wednesday, with immediate effect.
FCA looks to ban former Barclays Wealth exec Andrew Tinney
The Financial Conduct Authority has proposed that Andrew Tinney, formerly chief operating officer of Barclays Wealth and Investment Management, be publicly censured and banned from carrying out any senior financial roles.
US open: Stocks in the black as M&A activity provides a boost
US stocks were firmer in early trade following heavy losses in the previous session as M&A activity provided a boost.
Epwin Group revenue and profit well ahead in first half
Vertically integrated manufacturer of low maintenance building products, Epwin Group, announced its half year results for the six months to 30 June on Wednesday, with revenue rising 15. 5% to £143. 3m.
Shire gets FDA approval for primary immunodeficiency drug
The US Food and Drug Administration has granted approval for Shire’s Cuvitru drug for the treatment of patients with primary immunodeficiency, which is a group of more than 300 genetic disorders.
Thursday preview: BoE seen sitting tight, after Next and ONS retail numbers
Thursday's monetary policy announcement from the Bank of England is expected to see the rate-setting committee sit tight, with odds against an interest rate move increasing after relatively robust unemployment data was released.
Wilmington swings to loss on goodwill impairment
Business information and education services company Wilmington announced its full year results for the year to 30 June on Wednesday, with revenue up 11% to £105. 7m.
Small cap news round-up
Modern Water, an AIM listed provider for water and wastewater treatment and the monitoring of water quality, improved on its performance during the first half by cutting down on costs.
FTSE 100 movers: Glencore rallies but housebuilders lose ground
London’s FTSE 100 index was up 0. 3% to 6,682. 13 as investors digested some encouraging jobs data.
Rockhopper Exploration optimistic on potential of North Falkland basin
Rockhopper Exploration progressed on integrating its recent acquisitions, while completing a resource audit of its acreage in the North Falklands basin and increasing production from its Italian and Egyptian sites.
Ford 2017 results likely to take hit from investment in new technology
CEO of Ford Mark Fields admitted that the United States car manufacturer may suffer disappointing results in 2017, as the company invests heavily in new technology such as autonomous driving.
FTSE 250 movers: Galliford Try powers ahead while Redrow drags its feet
The FTSE 250 was just above the line in afternoon trading on Wednesday, as commodities provided a boost and investors took heart from solid jobs data.
Quadrise Fuels extends core fuel contract with AkzoNobel
Quadrise Fuels has extended two crucial agreements with Dutch chemicals giant AkzoNobel to continue developing a new form of marine fuel.
Results round-up
FTSE 250 homeware retailer Dunelm reported a rise in full-year profit as revenue increased and the company grew its market share despite the growth of new competition, particularly online.
Premier African begins lithium drilling programme, hires David Lenigas
Premier African Minerals, a South and West Africa based multi-commodity mining development company, has begun a diamond drilling programme on its Zulu lithium project.
Allergan to buy Vitae Pharmaceuticals in $639m deal
Allergan has agreed to buy clinical-stage biotechnology company Vitae Pharmaceuticals for $21 per share in cash, for a total transaction value of about $639m.
Modern Water clamps down on costs in first half
Modern Water, an AIM listed provider for water and wastewater treatment and the monitoring of water quality, improved on its performance during the first half by cutting down on costs.